LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Fibrinogen receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Fibrinogen receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Fibrinogen receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Fibrinogen receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Fibrinogen receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Fibrinogen receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Fibrinogen receptor antagonists and their use

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...

Fibrinogen receptor antagonists for inhibiting aggregation of bl

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Fibrinogen receptor antagonists for inhibiting aggregation of bl

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Fibrinolysis-enhancing agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Fibroblast growth factor (FGF23) polypeptides

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Fibroblast growth factor 11

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Fibroblast growth factor and nucleic acids encoding same

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Fibroblast growth factor conjugates

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Fibroblast growth factor conjugates

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Fibroblast growth factor-13

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Fibroblast growth factor-14

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Fibroin fluid and process for the production thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Fibronectin adhesion inhibitors